|

BBO-10203 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 2

Top Sponsors

  • TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)2

Indications

  • Metastatic Lung Cancer2
  • Lung Cancer2
  • Cancer2
  • KRAS Mutant Metastatic Colorectal Cancer1
  • Advanced Lung Carcinoma1

Birmingham, Alabama1 trial

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

O'Neal Comprehensive Cancer Center at UAB

Phase 1

Duarte, California1 trial

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

City of Hope Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.